Marisa Wexler, MS,  senior science writer—

Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.

Articles by Marisa Wexler

Virtual reality therapy may aid mental health, quality of life

An intervention combining talk therapy with virtual reality may help improve mental health and life quality for people with Parkinson’s disease, a study reports. “The results of this study demonstrated that [virtual reality-augmented cognitive behavioral therapy] significantly enhanced emotional well-being and quality of life in the experimental group compared…

Adapted physical activity eases Parkinson’s motor symptoms

An adapted physical activity program may help ease motor symptoms of Parkinson’s disease, a study showed. Although patients’ motor symptoms eased immediately after the three-month program, there didn’t appear to be a long-term effect on motor symptom severity, emphasizing a need for longer programs and/or further resources to…

Phase 2a trial of Jotrol as treatment for Parkinson’s planned

Jupiter Neurosciences said it’s planning a Phase 2a clinical trial to test Jotrol, the company’s oral formulation of resveratrol, as a treatment for Parkinson’s disease, in partnership with Zina Biopharmaceuticals. Zina will assist with aspects of the trial protocol, such as identifying biomarkers and selecting sites for the…